We strive to complete reports efficiently, providing treatment considerations to healthcare providers to enhance patient care in a timely manner. LIS (Laboratory Information System) integrations streamline workflows, enabling quick turnaround times (TAT) for results.

Each report is reviewed by a trained pharmacist and includes detailed recommendations for antimicrobial medications targeting specific detected pathogens. This approach simplifies decision-making for providers, particularly in cases involving multiple pathogens or resistance genes.

Our treatment considerations for medication selection, dosages, and durations are rooted in clinical practice guidelines (e.g., IDSA, CDC) and supported by primary literature.